FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Tandem Diabetes (NASDAQ: TNDM) reported Q3 EPS of $0.09, $0.03 better than the analyst estimate of $0.06. Revenue for the quarter came in at $179.6 million versus the consensus estimate of $171.37 million.
GUIDANCE:
Tandem Diabetes sees FY2021 revenue of $685-695 million, versus the consensus... More

